Goere D, Wagholikar G D, Pessaux P, Carrère N, Sibert A, Vilgrain V, Sauvanet A, Belghiti J
Department of Hepato-biliary Surgery, Hospital Beaujon, 100, bd du Gl Leclerc, Clichy, 92110, France.
Surg Endosc. 2006 May;20(5):721-5. doi: 10.1007/s00464-005-0583-x. Epub 2006 Feb 27.
The aim of this study was to evaluate the utility of staging laparoscopy in patients with biliary cancers in the era of modern diagnostic imaging.
From September 2002 through August 2004, 39 consecutive patients with potentially resectable cholangiocarcinoma underwent preoperative staging laparoscopy before laparotomy. Preoperative imaging included ultrasonography and triphasic computed tomography for all patients and magnetic resonance cholangiography in 35 patients (90%). Final pathological diagnosis included 20 hilar cholangiocarcinomas (HC), 11 intrahepatic cholangiocarcinomas (IHC), and eight gallbladder carcinomas (GBC).
During laparoscopy, unresectable disease was found in 14/39 patients (36%). The main causes of unresectability were peritoneal carcinomatosis (11/14) and liver metastases (5/14). At laparotomy, nine patients (37%) were found to have advanced disease precluding resection. Vascular invasion and nodal metastases were the main causes of unresectability during laparotomy (eight out of nine). In detecting peritoneal metastases and liver metastases, laparoscopy had an accuracy of 92 and 71%, respectively. All patients with vascular or nodal involvement were missed by laparoscopy. For prediction of unresectability disease, the yield and accuracy of laparoscopy were highest for GBC (62% yield and 83% accuracy), followed by IHC (36% yield and 67% accuracy) and HC (25% yield and 45% accuracy)
Staging laparoscopy ensured that unnecessary laparotomy was not performed in 36% of patients with potentially resectable biliary carcinoma after extensive preoperative imaging. In patients with biliary carcinoma that appears resectable, staging laparoscopy allows detection of peritoneal and liver metastasis in one third of patients. Both vascular and lymph nodes invasions were not diagnosed by this procedure. Due to these limitations, laparoscopy is more useful in ruling out dissemination in GBC and IHC than in HC.
本研究的目的是评估在现代诊断成像时代,分期腹腔镜检查在胆管癌患者中的应用价值。
从2002年9月至2004年8月,39例连续的可能可切除的胆管癌患者在剖腹手术前行术前分期腹腔镜检查。所有患者术前行超声检查和三期计算机断层扫描,35例患者(90%)行磁共振胆管造影。最终病理诊断包括20例肝门部胆管癌(HC)、11例肝内胆管癌(IHC)和8例胆囊癌(GBC)。
在腹腔镜检查中,14/39例患者(36%)发现不可切除疾病。不可切除的主要原因是腹膜种植转移(11/14)和肝转移(5/14)。在剖腹手术时,9例患者(37%)被发现有晚期疾病无法切除。血管侵犯和淋巴结转移是剖腹手术时不可切除的主要原因(9例中的8例)。在检测腹膜转移和肝转移方面,腹腔镜检查的准确率分别为92%和71%。所有有血管或淋巴结受累的患者均被腹腔镜检查漏诊。对于不可切除疾病的预测,腹腔镜检查的检出率和准确率在GBC中最高(检出率62%,准确率83%),其次是IHC(检出率36%,准确率67%)和HC(检出率25%,准确率45%)。
分期腹腔镜检查确保了在广泛的术前成像后,36%可能可切除的胆管癌患者未进行不必要的剖腹手术。在看似可切除的胆管癌患者中,分期腹腔镜检查可在三分之一的患者中检测到腹膜和肝转移。该检查未诊断出血管和淋巴结侵犯。由于这些局限性,腹腔镜检查在排除GBC和IHC的播散方面比在HC中更有用。